Supply of Hemlibra
Expired
Federal
ROCHE PRODUCTS PTY LTD
Awarded by National Blood Authority
The National Blood Authority engaged Roche Products Pty Ltd, an Australian private company based in Sydney, NSW, to supply Hemlibra under a limited-tender contract valued at AU$353,210,000 from October 2020 to June 2025. The procurement method was limited tender under exemption TR — 10.3.d.iii due to an absence of competition for technical reasons.
$353.2M
Contract Value
Contract Details
- Reference
- CN3727716
- Jurisdiction
- Federal
- Financial Year
- FY21
- Category
- Drugs and Pharmaceutical(UNSPSC: 51000000)
Description
Supply of Hemlibra
Key Dates
- Publish Date
- 4 Nov 2020
- Effective Date
- 31 Oct 2020
- End Date
- 29 June 2025
Published fields
- Procurement method
- Limited tender
- Location
- Not published in this source
Supplier
ROCHE PRODUCTS PTY LTD
- ABN
- 70 000 132 865
Agency
National Blood Authority
- ABN
- 87 361 602 478